IRADIMED CORPORATION Announces Executive Transition
April 28 2022 - 4:00PM
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced
today announced that Chris Scott, Chief Financial and Operating
Officer, has resigned from the Company effective May 27, 2022. Mr.
Scott started at the Company in December 2013 and is departing to
pursue other opportunities.
A formal search for a new CFO has commenced. The Company has
appointed Matt Garner, Controller, to the additional role of
interim CFO with immediate effect through the transition
period.
“Chris has been a valued partner over the past eight years.
Though he will be missed, he leaves us with a sound finance
department. Matt has also been with us for just over eight years
and is well prepared to step in as interim CFO with Chris providing
maximum support during the 30-day transition period,” said Roger
Susi, President and Chief Executive Officer of the Company.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in the development of
innovative Magnetic Resonance Imaging (“MRI”) compatible medical
devices. We develop, manufacture, market and distribute MRI
compatible medical devices and accessories, disposables and
services relating to them. To learn more about IRADIMED, visit
www.iradimed.com.
Media Contact:InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Jul 2023 to Jul 2024